logo
logo

LianBio Announces $310 Million Crossover Financing

LianBio Announces $310 Million Crossover Financing

10/29/20, 11:10 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/CN.svgshanghai
Money raised
$310 million
LianBio, a Chinese company focused on bringing paradigm-shifting medicines to patients in China and major Asian markets, today announced it has raised $310 million in an oversubscribed crossover financing, following its founding and initial financing provided by Perceptive Advisors.

Company Info

Company
Lian Bio
Location
shanghai, shanghai, china
Additional Info
LianBio’s mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in China and major Asian markets through partnerships that provide access to the best science-driven therapeutic discoveries. LianBio collaborates with world-class partners across a diverse array of therapeutic and geographic areas to build out a pipeline based on disease relevance and the ability to impact patients with transformative mechanisms and precision-based therapeutics. For more information, please visit lianbio.com.